【レポートの概要（一部）】
1. Report Overview
1.1 Multiple Sclerosis Drugs Market Overview
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by this Report
1.5 Who is this Report for?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQ)
1.8 Some Associated Reports
1.9 About Visiongain
2. Introduction to Multiple Sclerosis
2.1 What is Multiple Sclerosis?
2.1.1 Key Statistics: 2.5 Million Sufferers in the World
2.2 The Pathology of MS
2.2.1 Symptoms
2.3 Diagnosis of MS
2.3.1 Tests for MS Include These Technologies
2.4 Measuring MS
2.5 The Different Types of MS
2.5.1 Relapsing-Remitting MS (RRMS)
2.5.2 Secondary Progressive MS
2.5.3 Progressive Relapsing MS
2.5.4 Primary Progressive MS
2.5.5 Other Presentations of the Disease
2.6 Possible Causational Factors for MS
2.6.1 Genetic Factors
2.6.2 Infection
2.6.3 Environmental Factors and Less Well-Supported Theories
2.7 Demographics and Geographical Distribution
2.8 Different Treatments for MS
3. Leading Multiple Sclerosis Drugs
3.1 Copaxone (glatiramer acetate) by Teva Pharmaceutical Industries
3.1.1 First Non-Interferon Immunomodulator
3.1.2 Teva and the Approval of Generic Competition
3.1.3 The First Generic is Approved – Sandoz’s Glatopa
3.1.4 Industry Surprised by Copaxone’s Solid Sales, Despite Generic Competition: 40mg Dose is Key
3.1.5 Patents on Copaxone 40mg Being Contested – Although Teva Receives Good News in Europe
3.1.6 Copaxone Revenues 2011-2015
3.1.7 Copaxone Revenue Forecast 2016-2026
3.2 Tecfidera (dimethyl fumarate) by Biogen
3.2.1 Rapidly Grown Since 2013 to Become the Leading Oral MS Therapy
3.2.2 Tecfidera Revenues 2013-2015
3.2.3 Tecfidera Revenue Forecast 2016-2026
3.3 Avonex (interferon beta-1a) by Biogen
3.3.1 The Leading Interferon Therapy
3.3.2 Avonex Revenues 2011-2015
3.3.3 Patent Extension to 2026
3.3.4 Avonex Revenue Forecast 2016-2026
3.4 Gilenya (fingolimod) by Novartis
3.4.1 The First Oral Disease-Modifying Drug for MS
3.4.2 US Patent Trial and Appeal Board Sides Against Novartis
3.4.3 Gilenya Revenues 2011-2015
3.4.4 Gilenya Revenue Forecast 2016-2026
3.5 Rebif (interferon beta-1a) by Merck KGaA
3.5.1 Merck Attempting to Differentiate Rebif from Other Interferon Therapies
3.5.2 Rebif Revenues 2011-2015
3.5.3 Rebif Revenue Forecast 2016-2026
3.6 Tysabri (natalizumab) by Biogen
3.6.1 High Efficacy Offsets the Risks
3.6.2 Tysabri Revenues 2011-2015
3.6.3 Tysabri Revenue Forecast 2016-2026
3.7 Betaseron / Betaferon (interferon beta-1b) by Bayer
3.7.1 First Disease Modifying Drug for MS
3.7.2 Betaseron Revenues 2011-2015
3.7.3 Betaseron Revenue Forecast 2016-2026
3.8 Aubagio (teriflunomide) by Sanofi
3.8.1 More than 48,000 Patients Treated
3.8.2 Aubagio Revenues 2014-Q1 2016
3.8.3 Aubagio Revenue Forecast 2016-2026
3.9 Plegridy (peginterferon beta-1a) by Biogen
3.9.1 36% Reduction in ARR compared to Placebo
3.9.2 Plegridy Revenues 2014-2015
3.9.3 Plegridy Revenue Forecast 2016-2026
3.10 Lemtrada (alemtuzumab) by Sanofi
3.10.1 Very Effective, but with Side Effects
3.10.2 Lemtrada Past Revenues and Revenue Forecast 2016-2026
4. Multiple Sclerosis Drugs Pipeline 2016-2026
4.1 Ocrelizumab (Ocrevus / RG1594) by Roche
4.1.1 Humanised mAb Targeting CD20
4.1.2 First Drug to Receive Breakthrough Therapy Designation for MS
4.1.3 Exciting Latest Results from Two Phase 3 Trials
4.1.4 Ongoing Clinical Trials
4.1.5 Ocrelizumab Revenue Forecast 2016-2026
4.2 Ozanimod by Celgene
4.2.1 S1PR Modulator
4.2.2 Promising Results from Phase 2 RADIANCE Study
4.2.3 Ongoing Clinical Trials
4.2.4 Ozanimod in MS Revenue Forecast 2018-2026
4.3 Zinbryta (daclizumab high-yield process) by Biogen and AbbVie
4.3.1 Humanised mAb Being Jointly Developed by two Giants
4.3.2 Positive Opinion on Marketing Authorisation from the CHMP
4.3.3 Zinbryta Revenue Forecast 2016-2026
4.4 Ofatumumab by Novartis
4.4.1 Novartis Acquires Full Remaining Rights in $1bn Agreement
4.4.2 Advantages and Disadvantages over Ocrelizumab
4.5 Ponesimod by Actelion
4.5.1 S1PR Modulator
4.5.2 Positive Earlier Results
4.6 Laquinimod by Teva and Active Biotech
4.6.1 Troubled Oral Immunomodulator
4.6.2 Turned Down for European Licence
4.7 MED1003 by MedDay
4.7.1 Unique Method of Action
4.7.2 Results from MS-SPI and MS-ON
4.8 Masitinib by AB Science: Phase 3 and has Completed a Futility Analysis
4.9 Siponimod (BAF312) by Novartis: Competitor for Gilenya
5. Global Multiple Sclerosis Drugs Market 2016-2026
5.1 Global Multiple Sclerosis Drugs Market Forecast 2016-2026
5.2 What Factors Will Drive Growth in the Global MS Drugs Market?
5.2.1 Growth of Existing Products, Reaching Peak Blockbuster Revenues before Patent Expiry
5.2.2 Exciting New Products Due to be Launched Within the Next Ten Years
5.2.3 Premium Prices, Accompanied by Price Increases
5.2.4 Prevalence and Incidence of Multiple Sclerosis is Increasing
5.2.5 Unmet Needs and Strategic Partnering
5.3 What Factors will Restrain Growth in the Global MS Drugs Market?
5.3.1 Multiple Patent Expiries on Leading Drugs will Lead to Generic and Biosimilar Competition
5.3.2 Declining Healthcare Budgets Could Lead to Cost Pressures
5.3.3 Crowded Marketplace
6. Leading Therapeutic Segments: Revenue Prospects, 2016-2026
6.1 The Main Therapeutic Segments within the MS Drugs Market, Forecast 2016-2026
6.2 Therapeutic Composition of the Market in 2015, 2020 and 2026
6.3 Monoclonal Antibodies Segment Forecast 2016-2026
6.4 S1PR Modulator Segment Forecast 2016-2026
6.5 Interferons Segment Forecast 2016-2026
6.6 Other Immunomodulators Segment Forecast 2016-2026
6.7 ‘Others’ Segment Forecast 2016-2026
7. National Markets for MS Drugs: Revenue Prospects, 2016-2026
7.1 Multiple Sclerosis Cases and Prevalence Values
7.2 Leading Regional Markets Forecast 2016-2026
7.2.1 Regional Composition of the Market in 2015, 2020 and 2026
7.3 US MS Drugs Market
7.3.1 Reasons why the US Market Dominates the MS Drugs Market to Such an Extent
7.3.2 Undergoing Some Changes
7.3.3 US MS Drugs Market Forecast 2016-2026
7.4 EU5 MS Drugs Market 2016-2026
7.4.1 Common Characteristics of all the EU5 Nations in Regards to MS Drugs and Drivers of Growth
7.4.2 German MS Drugs Market: Leading EU Market
7.4.2.1 German MS Drugs Market Forecast 2016-2026
7.4.3 French MS Drugs Market: Strong Healthcare System
7.4.3.1 French MS Drugs Market Forecast 2016-2026
7.4.4 UK MS Drugs Market
7.4.4.1 UK MS Drugs Market Forecast 2016-2026
7.4.5 Italian MS Drugs Market
7.4.5.1 Italian MS Drugs Market Forecast 2016-2026
7.4.6 Spanish MS Drugs Market
7.4.6.1 Spanish MS Drugs Market Forecast 2016-2026
7.5 Canadian MS Drugs Market: Country has Highest Rate of MS in the World
7.5.1 Canadian MS Drugs Market Forecast 2016-2026
7.6 Japanese MS Drugs Market Forecast 2016-2026
7.7 Chinese MS Drugs Market Forecast 2016-2026
7.8 Indian MS Drugs Market Forecast 2016-2026
8. Conclusions from Our Research and Analysis
8.1 How will Revenues Change over the Forecast Period?
8.2 How will the Therapeutic Composition of the Market Change?
8.3 How will National Markets Develop from 2016 to 2026?
8.4 Concluding Remarks
【レポート販売概要】
■ タイトル：多発性硬化症治療薬の世界市場および研究開発展望2016-2026■ 英文：Multiple Sclerosis Drugs Market and R&D Outlook 2016-2026
■ 発行日：2016年6月
■ 調査会社：visiongain
■ 商品コード：VGAIN60619
■ 調査対象地域：グローバル
- 世界の携帯用酸素濃縮器市場2015The Global Portable Oxygen Concentrators Industry Report 2015 is a professional and in-depth study on the current state of the Portable Oxygen Concentrators industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Portable Oxygen Concentrators market analysis is provided for the international markets inclu …
- インドの教育用ハードウェア市場2016-2020About the Education Hardware Market Educational institutions deploy hardware to fulfill the purpose of learning and education. In the past few years, the use of PCs has increased because of the evolution of the learning and teaching methodology. Educational institutions are developing innovative teaching methods and relevant IT tools for students and staff for improved efficiencies and learning pr …
- クメンの世界市場予測Cumene 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about Cumene market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical part, the report …
- 世界の光ファイバコネクタ市場2015The Global Fiber Optic Connectors Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Fiber Optic Connectors industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Fiber Optic Connectors market analysis is provided for the international markets including d …
- グローバル建設市場の景況感レポート（2014年Q2）Construction Business Confidence Report Q2 2014 is a new report by Timetric that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the construction industry. This report also examines executives' opinions with regards to the current and future state of the economy, and its effect on the industry. It …
- 大気造水（AWG）の世界市場分析：製品別（冷却凝縮、湿潤乾燥）、用途別（産業、商業、住居）、セグメント予測The global AWG market is expected to reach USD 4.74 billion by 2024, according to a new report by Grand View Research, Inc. Increasing installations of AWG at commercial places such as banks, educational institutes, and municipal agencies is anticipated to have a positive impact on the industry growth over the next eight years. Atmospheric water generator requirements for industrial and commercial …
- CEPS A.S.：発電所及びSWOT分析2013CEPS A.S. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized and detailed …
- 世界のRFフィルタ市場2015The Global Radio Frequency Filters Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Radio Frequency Filters industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Radio Frequency Filters market analysis is provided for the international markets includin …
- グローバルIT市場機会予測（～2018）: BPOサービスSummary Kable's Market Opportunity Forecast outlines the primary findings from our ongoing research into the dynamics in the BPO service market. Key Findings This product provides revenue opportunity forecasts in the BPO Services market from 2014 to 2018, spanning six service lines, 37 geographical markets, six regions,14 verticals, and two size bands. Synopsis The extended scope of this product i …
- 世界のフローサイトメトリー（医療機器）市場：サプライヤーシェア及び市場予測Complete report $18,500. DataPack (test volumes, sales forecasts, supplier shares) $7,400.This 7-country report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the flow cytometry markets during the next five years. The report explores future marketing and technological trends in seven countries; provides market share estimates, …
- 航空機リースの世界市場2017-2021About Commercial Aircraft LeasingCommercial aircraft lease is a legal arrangement used by airlines and other aircraft operators or leasing companies for reducing the financial burden of the airlines while procuring new aircraft. As aircraft are flexible in deployment and their supply is limited, leasing them via short, medium, or long term operating lease contracts allows airlines to maintain stea …
- スマートスピーカーの世界市場2019-2023Global Smart Speaker Market: About this market Smart speakers are internet-enabled that are controlled by voice commands. Technavio’s smart speaker market analysis considers sales to residential users and commercial users' segments. Our analysis also considers the sales of smart speaker in APAC, Europe, MEA, North America, and South America. In 2018, the residential users segment held the highest …
- ローラーベアリングの世界市場About Roller BearingsRoller bearings are a type of antifriction bearings. Roller bearings are similar to ball bearings; however, roller bearings, unlike the balls in ball bearings, use cylindrical rollers. Roller bearings have higher radial load capacity than ball bearings. Technavio’s analysts forecast the global roller bearings market to grow at a CAGR of 4.33% during the period 2017-2021. [Cove …
- 企業アプリケーションおよびクラウド環境におけるBYOD市場Bring your own device (BYOD) has become one of the most popular topics in information technology resulting from employees bringing their personal devices into the enterprise and then wanting to use them to access company information such as email and various enterprise files. As the trend continues, bring your own technology will eventually facilitate user's integrating many device types (smartpho …
- 機械状態監視の世界市場2016-2020About the Machine Condition Monitoring Market During the course of the 20th century, maintenance strategies have gone through many changes. Currently, predictive and proactive strategies present the maximum benefits at minimum expenditure. However, the preventive or scheduled maintenance approach is the most widely used strategy, particularly among the SMEs. This is mainly due to their reluctance …
